This may be due to an effect of prenatal growth on the pathogenesis of early disease, by “programming” the development of risk factors (e.g., insulin/glucose metabolism, hypertension, and lipid metabolism) (5, 6) or due to altered “stability” of established physiological conditions (6). The gene discussed is INS; the disease is hypertensive disorder.